BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7718245)

  • 1. Structural determinants of allosteric regulation in alternatively spliced AMPA receptors.
    Partin KM; Bowie D; Mayer ML
    Neuron; 1995 Apr; 14(4):833-43. PubMed ID: 7718245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple molecular determinants for allosteric modulation of alternatively spliced AMPA receptors.
    Quirk JC; Nisenbaum ES
    J Neurosci; 2003 Nov; 23(34):10953-62. PubMed ID: 14645491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.
    Partin KM; Patneau DK; Mayer ML
    Mol Pharmacol; 1994 Jul; 46(1):129-38. PubMed ID: 8058047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation of AMPA receptors by cyclothiazide in two types of striatal neurons.
    Vorobjev VS; Sharonova IN; Haas HL; Sergeeva OA
    Eur J Neurosci; 2000 Aug; 12(8):2871-80. PubMed ID: 10971630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPA receptor heterogeneity in rat hippocampal neurons revealed by differential sensitivity to cyclothiazide.
    Fleck MW; Bähring R; Patneau DK; Mayer ML
    J Neurophysiol; 1996 Jun; 75(6):2322-33. PubMed ID: 8793745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of AMPA receptors on isolated amacrine-like cells in carp retina.
    Shen Y; Zhou Y; Yang XL
    Eur J Neurosci; 1999 Dec; 11(12):4233-40. PubMed ID: 10594649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
    Partin KM; Mayer ML
    Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of oligodendroglial excitotoxicity.
    Yoshioka A; Bacskai B; Pleasure D
    J Neurosci Res; 1996 Nov; 46(4):427-37. PubMed ID: 8950702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing.
    Koike M; Tsukada S; Tsuzuki K; Kijima H; Ozawa S
    J Neurosci; 2000 Mar; 20(6):2166-74. PubMed ID: 10704491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
    Johansen TH; Chaudhary A; Verdoorn TA
    Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of desensitization at glutamate receptors in isolated crucian carp horizontal cells by concanavalin A, cyclothiazide, aniracetam and PEPA.
    Shen Y; Lu T; Yang XL
    Neuroscience; 1999 Mar; 89(3):979-90. PubMed ID: 10199629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants responsible for differences in desensitization kinetics of AMPA receptor splice variants.
    Quirk JC; Siuda ER; Nisenbaum ES
    J Neurosci; 2004 Dec; 24(50):11416-20. PubMed ID: 15601947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel allosteric potentiator of AMPA receptors: 4--2-(phenylsulfonylamino)ethylthio--2,6-difluoro-phenoxyaceta mide.
    Sekiguchi M; Fleck MW; Mayer ML; Takeo J; Chiba Y; Yamashita S; Wada K
    J Neurosci; 1997 Aug; 17(15):5760-71. PubMed ID: 9221774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interface interactions modulating desensitization of the kainate-selective ionotropic glutamate receptor subunit GluR6.
    Zhang Y; Nayeem N; Nanao MH; Green T
    J Neurosci; 2006 Sep; 26(39):10033-42. PubMed ID: 17005866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
    Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
    Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A.
    Partin KM; Patneau DK; Winters CA; Mayer ML; Buonanno A
    Neuron; 1993 Dec; 11(6):1069-82. PubMed ID: 7506043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclothiazide potentiates agonist responses at human AMPA/kainate receptors expressed in oocytes.
    Sharp RL; May PC; Mayne NG; Snyder YM; Burnett JP
    Eur J Pharmacol; 1994 Jan; 266(1):R1-2. PubMed ID: 7511109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.
    Partin KM; Fleck MW; Mayer ML
    J Neurosci; 1996 Nov; 16(21):6634-47. PubMed ID: 8824304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
    Pittaluga A; Bonfanti A; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.